Physiology of DIC After Massive Blood Product Transfusion

Core Pathophysiologic Mechanisms

• DIC following massive transfusion develops through a cascade of dilutional coagulopathy, consumption of clotting factors, and activation of systemic coagulation pathways triggered by tissue trauma, hypoxia, hypothermia, and hypovolemic shock 1, 2

Sequential Factor Depletion

• Fibrinogen depletes first, reaching critical levels after approximately 150% blood volume loss 1
• Other labile coagulation factors (factors V, VIII, XI) decrease to 25% activity after 200% blood volume replacement 1
• PT and APTT prolongation to 1.5 times normal correlates with increased clinical bleeding risk 1

Triggering Factors for DIC Progression

• Prolonged hypoxia or hypovolemia - tissue hypoperfusion activates endothelial injury and tissue factor release 2
• Hypothermia - cold resuscitation fluids impair enzymatic coagulation reactions and platelet function 2

Consumption vs. Dilution

• DIC: disproportionate consumption with PT/APTT prolongation beyond expected dilution, profound thrombocytopenia, fibrinogen <1.0 g/L, and elevated fibrin degradation products or D-dimers 1, 3

Laboratory Markers of Progression

• Platelet count decline >30% from baseline suggests subclinical DIC progression 4, 3
• Fibrinogen <1.5 g/L indicates severe consumption requiring replacement 4, 3
• PT/APTT prolongation beyond dilutional expectations (>1.5× normal) 1
• Elevated D-dimers or fibrin degradation products confirm fibrinolytic activation 1

Microvascular Thrombosis and Organ Dysfunction

• Widespread microvascular fibrin deposition causes organ ischemia 2
• Consumption of platelets and clotting factors produces bleeding diathesis 3

Critical Clinical Implications

• Early recognition before microvascular bleeding becomes evident is essential, as DIC carries considerable mortality and becomes difficult to reverse once established 1, 2